Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07771465Phase 3Recruiting
- Sponsor
- Kardigan
- Start
- Aug 2026
- Primary completion
- Nov 2032
- Countries
- 11
01
Overview
A Phase 3 trial of danicamtiv in dilated cardiomyopathy (DCM), sponsored by Kardigan. Started Aug 2026; status: recruiting.
02
Drugs
danicamtiv
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT07771465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07771465.